Russell Investments Group, Ltd. - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 172 filers reported holding INTERSECT ENT INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$553,000
-37.7%
19,749
-39.2%
0.00%0.0%
Q4 2021$887,000
-27.5%
32,487
-27.8%
0.00%
-50.0%
Q3 2021$1,223,000
+115.3%
44,972
+35.2%
0.00%
+100.0%
Q2 2021$568,000
-65.1%
33,254
-57.4%
0.00%
-66.7%
Q1 2021$1,626,000
-28.2%
77,989
-21.2%
0.00%
-25.0%
Q4 2020$2,266,000
+29.5%
98,978
-7.8%
0.00%0.0%
Q3 2020$1,750,000
+51.9%
107,352
+26.0%
0.00%
+33.3%
Q2 2020$1,152,000
+85.2%
85,191
+62.0%
0.00%
+50.0%
Q1 2020$622,000
+131.2%
52,575
+343.6%
0.00%
+100.0%
Q2 2019$269,000
-69.9%
11,851
-57.4%
0.00%
-50.0%
Q1 2019$893,000
-36.1%
27,794
-44.0%
0.00%
-33.3%
Q4 2018$1,398,000
-1.6%
49,661
+0.5%
0.00%0.0%
Q3 2018$1,421,000
-9.3%
49,408
+18.1%
0.00%0.0%
Q2 2018$1,567,000
-21.0%
41,819
-17.2%
0.00%0.0%
Q1 2018$1,984,000
+85.4%
50,497
+55.1%
0.00%
+50.0%
Q4 2017$1,070,000
-24.2%
32,564
-28.1%
0.00%0.0%
Q3 2017$1,411,000
+32.1%
45,315
+18.6%
0.00%0.0%
Q2 2017$1,068,000
+77.4%
38,214
+8.8%
0.00%
+100.0%
Q1 2017$602,000
+59.7%
35,124
+11.4%
0.00%0.0%
Q4 2016$377,00031,5300.00%
Other shareholders
INTERSECT ENT INC shareholders Q1 2018
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders